News

Article

Study identifies risk factors associated with Diabetic Retinopathy in youth with Type 1 Diabetes

Author(s):

The investigators conducted a retrospective chart review of patients’ demographic and clinical data from 2005 to 2020.

(Image Credit: AdobeStock/rkris)

(Image Credit: AdobeStock/rkris)

A chart review showed that diabetic retinopathy (DR) is associated with older age, longer duration of type 1 diabetes, earlier onset of type 1 diabetes, and some modifiable risk factors.

The results, according to first author Konstantina Sampani, MD, indicated that maintaining control of blood pressure (BP) and hemoglobin A1c (HbA1c) are key to preventing the onset of DR. Sampani, who is from the Joslin Diabetes Center Beetham Eye Institute, Boston, presented the findings of her group at the Association for Research in Vision and Ophthalmology annual meeting in Seattle.

The investigators conducted a retrospective chart review of patients’ demographic and clinical data from 2005 to 2020.

The investigators used spectral-domain optical coherence tomography (SD-OCT) macular scans for a subset of patients and automated retinal layer segmentation to determine the inner and outer layers (IRL, ORL). The researchers sought correlations between the patient demographics, body mass index (BMI), blood pressure (BP), HbA1c, and retinal layer cell thickness and volume with the presence of DR, she recounted.

Important findings

The demographic data from the cohort were as follows. A total of 1,359 patients (2,704 eyes; 49.6% female; mean age, 13.7±4.3 years) were included. The mean duration of the type 1 diabetes was 7.0±5.2 years, the mean age at onset of type 1 diabetes, 7.7±4.7 years; mean HbA1c, 8.4±1.3%; mean BMI, 21.9±4.3; mean systolic BP, 109.2±10.4; and mean diastolic BP, 65.8±7.4.

Of the 2,704 eyes, 139 (5.14%) had DR, of which 5.1% was nonproliferative and 0.04% was proliferative.

The following significant correlations were found with the presence of DR: older age (p<0.001), longer duration of type 1 diabetes (p<0.001), earlier onset of type 1 diabetes (p<0.04), higher HbA1c (p<0.001), and high systolic and diastolic BP (each p<0.001). They also pointed out that these correlations remained significant after adjusting for age, gender, HbA1c, duration of type 1 diabetes, and the age at onset of type 1 diabetes.

A subset of 109 eyes (69 patients) who had SD-OCT images and no DR had higher HbA1c values that were associated significantly with thinner central subfield thickness (p = 0.001) and thinner IRL (p=0.004). Higher systolic BP also was correlated significantly with increased IRL volume (p=0.02). No significant relationships were identified between the total IRL or ORL thickness and the BMI, diastolic BP, or duration of type 1 diabetes.

The study underscored the significant associations seen with older age, longer disease duration, earlier disease onset, and some modifiable risk factors, and the importance of controlling BP and HbA1c to prevent disease onset.

In addition, the correlation between higher HbA1c and thinner IRL in eyes without DR may mean that neurodegeneration is associated with worse glycemic and BP control. The authors emphasized that their results highlight the importance of controlling modifiable risk factors to prevent DR and potentially reduce subclinical neural retinal loss in young patients with type 1 diabetes.

Reference
Sampani K, Keady J, Silva PS, et al. Risk factors for diabetic retinopathy and neural retinal degeneration in youth with type 1 diabetes. Paper presented at the Association for Research in Vision and Ophthalmology annual meeting; May 5-9, 2024, Seattle, WA. Presentation number: 956

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.